This cluster includes six patients with congenital anaemias characterised by erythroid cell loss at a stage that is later than BFU-E (i.e. HbS, spherocytosis, CDA II and Beta thalassemia), and five patients with acquired conditions. This evidence concerns the gene CDA and Spherocytosis.